1. Home
  2. TNXP vs SSKN Comparison

TNXP vs SSKN Comparison

Compare TNXP & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • SSKN
  • Stock Information
  • Founded
  • TNXP 2007
  • SSKN 1989
  • Country
  • TNXP United States
  • SSKN United States
  • Employees
  • TNXP N/A
  • SSKN N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • SSKN Medical/Dental Instruments
  • Sector
  • TNXP Health Care
  • SSKN Health Care
  • Exchange
  • TNXP Nasdaq
  • SSKN Nasdaq
  • Market Cap
  • TNXP 19.5M
  • SSKN 12.5M
  • IPO Year
  • TNXP N/A
  • SSKN 2005
  • Fundamental
  • Price
  • TNXP $0.61
  • SSKN $2.89
  • Analyst Decision
  • TNXP Strong Buy
  • SSKN
  • Analyst Count
  • TNXP 2
  • SSKN 0
  • Target Price
  • TNXP $53.50
  • SSKN N/A
  • AVG Volume (30 Days)
  • TNXP 202.6M
  • SSKN 8.1K
  • Earning Date
  • TNXP 11-12-2024
  • SSKN 11-13-2024
  • Dividend Yield
  • TNXP N/A
  • SSKN N/A
  • EPS Growth
  • TNXP N/A
  • SSKN N/A
  • EPS
  • TNXP N/A
  • SSKN N/A
  • Revenue
  • TNXP $11,291,000.00
  • SSKN $32,674,999.00
  • Revenue This Year
  • TNXP $62.53
  • SSKN $0.94
  • Revenue Next Year
  • TNXP $26.17
  • SSKN $11.30
  • P/E Ratio
  • TNXP N/A
  • SSKN N/A
  • Revenue Growth
  • TNXP 183.05
  • SSKN N/A
  • 52 Week Low
  • TNXP $0.12
  • SSKN $2.51
  • 52 Week High
  • TNXP $14.08
  • SSKN $6.50
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 75.02
  • SSKN 42.17
  • Support Level
  • TNXP $0.32
  • SSKN $2.96
  • Resistance Level
  • TNXP $0.72
  • SSKN $3.15
  • Average True Range (ATR)
  • TNXP 0.15
  • SSKN 0.12
  • MACD
  • TNXP 0.04
  • SSKN -0.01
  • Stochastic Oscillator
  • TNXP 39.61
  • SSKN 9.09

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Share on Social Networks: